Introduction
African horsesickness, which is endemic in sub-Saharan Africa, is a gnat (Culicoides)-transmitted disease of horses, mules and donkeys; goats, zebras, ferrets and dogs are also susceptible. In severe cases death occurs from pulmonary oedema. The aetiological agent is an orbivirus classified in the Reoviridae family, African horsesickness virus (AHSV), of which nine serotypes are recognized. Like that of bluetongue virus (BTV), the dsRNA genome of AHSV consists of 10 segments located within an icosahedral core particle, which is composed of two major (VP3 and VP7) and three minor (VP 1, VP4 and VP6) proteins. The core is surrounded by two other proteins (VP2 and VP5), which form a loosely bound outer capsid. Unlike BTV, little is known about the molecular biology of AHSV.
Recently, several outbreaks of the disease have occurred in Spain and Portugal. To develop suitable diagnostic reagents and rational strategies to control and prevent the disease induced by AHSV, we have investigated the structure-function relationships of the various genes and gene products of an AHSV-4 isolate recovered in Spain. Since VP7 has been identified as a group-specific antigen for BTV (Huismans & Erasmus, 1981 ; Gumm & Newman, 1982; Hiibschle & Jang, 1983; Oldfield et al., 1990) , we initially investigated the AHSV gene [RNA segment 7 ($7)] that encodes VP7. The complete sequence of the gene was obtained from clones of $7 cDNA . In this work we describe the construction and isolation of a recombinant baculovirus containing the cloned $7 cDNA. The strong polyhedrin promoter of Autographa californica nuclear polyhedrosis virus (AcNPV) was used to obtain high level expression of VP7. The recombinant produces AHSV-4 VP7 in infected Spodopterafrugiperda (St') cells; its antigenic properties were analysed and compared with those of BTV VP7 using a panel of anti-BTV and anti-AHSV polyclonal sera, as well as the available monoclonal antibodies (MAbs). The biologically active form of VP7 was purified, and its utility for diagnosis of AHSV infections was demonstrated using an ELISA.
Methods
Virus and cells. Sf cells were grown in suspension or monolayer cultures at 28 °C in TC100 medium supplemented with 10% foetal calf serum (FCS). AcNPV and recombinant baculoviruses were plaquepurified and propagated as described by Brown & Faulkner (1977) .
DNA manipulations and recombinant transfer vector contruction.
Standard DNA manipulation techniques were used to construct recombinant baculovirus transfer vectors (Maniatis et al., 1982) . Restriction enzymes, T4 DNA ligase and the Klenow fragment of DNA polymerase were purchased from Amersham. Calf intestinal alkaline phosphatase was obtained from Boehringer Mannheim. The construction of plasmid pAcYM1/AHSV4.7 is summarized in Fig. 1 . The full-length cDNA representing AHSV-4 $7 dsRNA was released from the pBR322 cloning vector by PstI digestion, and the homopolymeric tails added in the original cloning procedure were removed by digestion with Bal 31 . The products were then repaired using the Klenow fragment of DNA polymerase and inserted into pUC4K, digested previously with SalI, repaired and dephosphorylated as shown in Fig. 1 . The terminal sequences of candidate inserts were sequenced according to Maxam & Gilbert (1980) and a clone retaining the entire coding region as well as 7 bp upstream of the ATG start codon was selected and ligated into the BamHI site of the baculovirus transfer vector pAcYM1 (Matsuura et al., 1987) . The derived recombinant transfer vectors were characterized by restriction enzyme mapping and sequence analyses. One of the recombinant vectors (pAcYM 1/AHSV4.7) was selected; this construct contained the AHSV $7 gene inserted in the correct orientation for expression directed by the AcNPV polyhedrin promoter.
Transfection and selection of recombinant baculoviruses. To obtain recombinants, cotransfections were performed by the lipofectin method using linearized AcRP6SC baculovirus DNA to increase the level of recombination, as previously described (Kitts et al., 1990) . The lipofectin mixture (8 ~tl lipofectin and 4 ill water) was added dropwise to the cotransfection mixture (12 ill containing 1 lig of pAcY-M1/AHSV4.7 DNA and 50 ng of linearized AcRP6SC baculovirus DNA) and incubated for 15 min at room temperature. The mixture was inoculated onto a 35 mm tissue culture dish containing 1.5 x 106 Sfcells in 1 ml serum-free TC100 and incubated for 5 to 24 h at 28 °C. TCI00 (1 ml) containing 10% FCS was then added to the cells, and the supernatant was harvested at 48 h, when c.p.e, was detectable. Recombinants, selected by virtue of their ability to express ANSV-4 VP7 as demonstrated by Western immunoblot analyses, were subsequently plaque-purified (Matsuura et al., 1987) .
PAGE and Western blot analyses of recombinant proteins. Sf cells in 35 mm tissue culture dishes were infected with virus at a multiplicity of 10 p.f.u./cell, the cells were incubated at 28 °C, and then rinsed three times with PBS and lysed in 150 Ill of RIPA buffer (1% Triton X-100, 1% sodium deoxycholate, 0.5 M-NaC1, 0"05 M-Tris-HCI pH 7.4, 0.01 M-EDTA, 0.1% SDS). Aliquots of protein samples were boiled for 10 min in dissociation buffer (2.3% SDS, 10% v/v glycerol, 5% v/v 2-mercaptoethanol, 62.5 mM-Tris-HC1 pH 6.8, 0-01% bromophenol blue) and analysed by 10% PAGE in the presence of SDS (Laemmli, 1970) . After electrophoresis, proteins were either stained with Kenacid blue or blotted onto an Immobilon membrane using a semi-dry electroblotter. The blot was incubated for 1 h at room temperature in blocking solution (5% w/v milk powder and 0.1% NP40 in PBS), then transferred to a blocking solution containing the first antibody and incubated for 1 h at room temperature. After three washes of 10 min each in the same buffer, the blot was incubated for 1 h at room temperature in blocking buffer containing an appropriate alkaline phosphatase-conjugated IgG (Sigma). Following further washes in PBS alone, bound antibody was detected using 5-bromo-4-chloro-3-indolyl phosphate and nitro blue tetrazolium chloride (Gibco) as substrates for the alkaline phosphatase.
Electron micrographs of infected cells.
Sf cells were infected with recombinant baculovirus at a multiplicity of 10 p.f.u./cell and incubated at 28 °C for 3 days. The cells were washed with PBS, fixed with 2% glutaraldehyde and treated with 1% osmic acid. Cell sections were observed in a JEOL electron microscope.
Protein labelling and immunoprecipitation analyses. Sf cells were infected with either recombinant virus (AcAHSV-4.7 or AcBTV-10.7) or wild-type AcNPV at a multiplicity of 5 p.f.u./cell in 35 mm tissue culture dishes (1.5 x 106 cells/dish) and incubated at 28 °C. At the time of maximum protein expression (approximately 60 lig/1-5 x 106 cells), the cells were incubated for 1 h at 28 °C in methionine-and serum-free medium to reduce the intracellular pools of the precursor. The cells were then labelled overnight at 28 °C with 50 pCi [3sS]methionine (Amersham; 800 Ci/mmol) in methionine-and serum-free medium. After the labelling period, the medium was removed, the monolayers were rinsed three times with PBS and the cells were lysed in 200 til RIPA buffer. Aliquots (50 I~1) of these extracts were then incubated with 5 pl of antibody in 450 Ill RIPA buffer overnight at 4 °C. Fifty microlitres of a 30% solution of Protein A-Sepharose CL-4B beads (Sigma) was added, and the mixture was incubated overnight at 4 °C. The beads were then washed three times with ice-cold RIPA buffer and the immune complexes were removed from the beads by boiling for 5 min in dissociation buffer (see above). Aliquots of the supernatant were subjected to 10% PAGE in the presence of SDS as described by Laemmli (1970) . After electrophoresis the gels were fixed in 10% (v/v) acetic acid, dried and exposed to X-ray film.
Purification of AHSV VP7 expressed in Sf cells. AcAHSV-4.7-infected Sf cells (2 x 109) were harvested 4 days post-infection by centrifugation at 3000 r.p.m, for 15 min at 4 °C and rinsed in PBS. Cell pellets were resuspended in 24 ml of 10 mM-Tris-HC1 pH 7.5, 150 mMNaCI containing 0.5% NP40 and left on ice for 15 min. The treated cells were then recentrifuged at 1000 r.p.m, for 10 min to remove cell debris. The supernatant was loaded onto a 30% to 80% (w/v, 10 ml) continuous sucrose gradient in 10 mM-Tris-HC1 pH 7.5. The gradients were centrifuged at 26000 r.p.m, for 2 h at 4 °C in an SW41 rotor (Beckman), and 1 ml fractions were collected. Samples containing AHSV VP7 were pooled and dialysed overnight at 4 °C in 10 mM-Tris-HC1 pH 7.5. Insoluble material was removed by low-speed centrifuga-180K--tion, and the supernatant medium was freeze-dried and stored at -20 °C.
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ELISA using purified VP7. Each well of a 96-well PVC microtitre 58K--plate (Flow Laboratories) was coated overnight at 4 °C with 50 lal VP7 (i.e. approximately 100 ng/well) in 0-1 M-sodium bicarbonate pH 9-5. 48.5K--After adsorption of the antigen, the plates were saturated in blocking buffer [5% skimmed milk powder in TBS (144 mM-NaCI in 25 mMTris-HCl pH 7.6)] for 30 rain at room temperature. Following three 36.5K--washes in blocking buffer, the plates were incubated with 200 p.l/well of serial dilutions of reference anti-AHSV-4 horse serum or anti-BTV-10 26-5K-rabbit serum diluted in blocking buffer, for 1 h at room temperature. After three washes in the same buffer, the plates were incubated with 200 lal/well of 1 : 1000 dilution of anti-horse or anti-rabbit IgG-alkaline phosphatase conjugate (Sigma) for 1 h at room temperature. Following three washes in TBS alone, the enzyme-linked secondary antibodies were detected using p-nitrophenyl phosphate disodium substrate (Sigma) in 1 M-Tris-HCI pH 8.0. The absorbance at 405 nm was measured using a multichannel spectrophotometer.
Results

Construction of a recombinant transfer vector and selection of recombinant baculoviruses
A r e c o m b i n a n t baculovirus transfer vector containing the A H S V -4 $7 sequence was constructed as described in Methods (Fig. 1) viruses from the transfection were screened by W e s t e r n i m m u n o b l o t analysis using a n t i -A H S V -4 polyclonal serum and r e c o m b i n a n t s expressing VP7 were selected (frequency a p p r o x i m a t e l y 20%). After three further plaque purification steps, three putative r e c o m b i n a n t s were obtained. N o difference in the phenotypes of the three viruses was detected in terms of the size or a m o u n t of virus-induced protein synthesized. One of the recombinants ( A c A H S V -4 . 7 ) was chosen for further analyses.
High-level expression of AHSV-4 VP7 causes crystal formation in Sf cells
Confluent monolayers of Sf cells were mock-infected or infected at a multiplicity of 5 p.f.u./ceU with either A c N P V or A c A H S V -4 . 7 . F o r comparison, cells were also infected with the recombinant baculovirus AcBTV-10.7, expressing BTV-10 VP7 (Oldfield et al., 1990) . The proteins were resolved by S D S -P A G E and stained with Kenacid blue (Fig. 2) , or analysed by Western immunoblotting ( Fig. 3a and b) . As shown in Fig. 2 , by comparison with mock-infected and AcNPV-infected Sf cell controls, cells infected with AcAHSV-4.7 synthesized a major 38K protein, i.e. similar to the predicted AHSV-4 $7 gene product and equivalent to the recombinant BTV-10 VP7 (Oldfield et al., 1991 ; Fig. 3) . Maximum expression of VP7 was obtained 4 days post-infection. The level of expression of AHSV-4 VP7 was estimated to be approximately 60 mg/2 × 109 infected Sf cells.
Confirmation that the expressed 38K protein represented authentic AHSV polypeptide was provided by Western blot analyses using a polyclonal anti-AHSV-4 horse antiserum (Fig. 3a) . This antiserum reacted strongly with VP7 in AcAHSV-4.7-infected Sf cells, whereas no reaction was detected with proteins from AcNPV-infected Sf cells.
To determine whether AHSV and BTV VP7 crossreact, the AHSV-4 VP7 and BTV-10 VP7 samples expressed from the respective recombinant baculoviruses were resolved by SDS-PAGE and subjected to Western immunoblot analyses using either the polyclonal anti-AHSV-4horse antiserum (Fig. 3a) or a polyclonal anti-BTV-10 rabbit antiserum (Fig. 3b) . As shown in Fig. 3 (a) , only a faint reaction (if any) was obtained between the anti-AHSV-4 antiserum and BTV-I 0 VP7, and none was detected between the anti-BTV-10 antiserum and AHSV-4 VP7 (see below).
Since the level of AHSV VP7 expression was very high as judged by the levels of stained protein (Fig. 2) , it was of interest to determine whether the recombinant virusinfected cells showed any visible structures, as previously observed in AHSV virus-infected BHK21 cells (Oellermann, 1970; P. Mertens, personal communication) . As shown in Fig. 4 (a) (arrows) , when examined under a light microscope infected cells exhibited distinct disc-shaped crystals; mock-infected cells, AcNPV-infected cells (Fig.  4b , arrow highlights viral polyhedra), and cells infected with other types of recombinant baculoviruses (see Matsuura et al., 1987) lacked such structures. The AHSV VP7 structures exhibited variations in both size and number per cell, usually containing between one and three crystals (Fig. 4a) . Electron micrographs of AcAHSV-4.7-infected cells (Fig. 4c) confirmed the presence of disc-shaped crystals in the nucleus and cytoplasm of infected cells.
These morphological structures were subsequently purified on a linear sucrose gradient as described in Methods, and the authenticity of the expressed protein was confirmed by Western blot analysis (data not shown).
Recombinant VP7 is a group-specific immunogenic antigen and shares common antigenic determinants with other orbiviruses
Recently we have demonstrated that BTV VP7 is not only recognized by all anti-BTV antisera, but also by anti-AHSV antisera (Oldfield et al., 1990) . Therefore it was of interest to determine whether AHSV VP7 exhibited similar cross-reactive capabilities with all anti-AHSV antisera as well as with antisera to BTV and the related epizootic haemorrhagic disease virus (EHDV). To determine whether the AHSV VP7 expressed could react with antibodies representing the nine AHSV serotypes, purified VP7 was coated onto microwell plates (100ng/well) and tested by ELISA using polyclonal antisera to the nine AHSV serotypes. The recombinant AHSV-4 VP7 was recognized by all the anti-AHSV antisera tested (data not shown). Similarly, sera from infected animals or from animals vaccinated with either monovalent or polyvalent AHSV vaccines reacted equally well. Subsequently a comparative EL1SA was performed using AHSV and BTV-10 VP7, and homologous and heterologous polyclonal antisera. As shown in Table 1 , the cross-rectivity of anti-BTV and anti-EHDV antisera with recombinant AHSV VP7 was dectectable but significantly lower than that with homologous antiserum. Similarly, low cross-reactivity was observed between recombinant BTV-10 VP7 and anti-AHSV-4 antiserum (Table 1) . However, BTV-10 VP7 reacted well with anti-EHDV-1 antisera, as expected. The data indicate the existence of few common antigenic determinants in the two viruses.
The antigenic relationships were analysed further by Western blot analysis and by immunoprecipitation studies. For these experiments, polyclonal sera against AHSV, BTV and EHDV, as well as a panel of anti-AHSV and anti-BTV VP7 MAbs were used. The results are presented in Fig. 5 and are summarized in Table 2 . The data obtained with the polyclonal sera clearly indicated that AHSV and BTV VP7 cross-react in immunoprecipitation analyses (Fig. 5) . The cross-reactivities of the antisera were not, or were only faintly detectable by Western immunoblot analyses (Table 2) . This suggests the existence of one major, perhaps conformational and immunodominant, determinant on each VP7. The results were confirmed by the reactivities observed using the four different MAbs (Fig. 5 and Table  2 ). In immunoprecipitation analyses, the anti-BTV MAb reacted strongly with BTV VP7 and to a lesser extent with AHSV VP7 (Fig. 50 . However, since it did not show similar positive signals in Western blot assays with either BTV VP7 or AHSV VP7, it can be inferred that the shared epitope is conformational rather than linear. 3  1  2 3  !  2  3  1 2  3  1  2  3  1  2  3  1 2 3  1  2  3 By contrast, three anti-AHSV MAbs (MAbs 5G5, 3D2 and 4AH9) recognized one linear epitope on AHSV-4 VP7 (Table 2 ) which is apparently shared by BTV VP7. The reactivity of these three MAbs with BTV VP7 was very low, suggesting that a related but not identical sequence is involved. The anti-EHDV antibodies did not react with the AHSV or BTV antigens in Western blot assays (Table 2 ). Whether the negative result was due to relatively low titres is not clear. However, they did exhibit low but definite reactivities in the immunoprecipitation tests (Fig. 5 d, e) .
Discussion
The complete sequence of AHSV-4 $7, encoding VP7, one of the major core proteins of the virus, has been published recently and shown to be closely related to that of BTV $7 . To study the structurefunction relationships of BTV and AHSV VP7, AHSV-4 $7 cDNA was expressed using baculovirus vectors. AHSV VP7 was synthesized at high level in Sf cells and reached a maximum by 4 days post-infection, estimated (based on stained gels) to be 60 mg AHSV VP7/I, which contains 2 x 109 AcAHSV-4.7-infected Sf cells. This phenotype differed from that of the BTV VP7 recombinant constructed using the same baculovirus vector, in which BTV VP7 reached a maximum by 2 days postinfection. Interestingly, AHSV VP7 synthesized in Sf cells selfassembled to form disc-shaped crystal structures visible by 2 days post-infection. In general, up to three structures per cell were identified, with a maximum diameter of 25 gm and length of 250 ktm. This is in agreement with the observations made on AHSV-infected BHK ceils (Oellerman, 1970; P. Mertens, personal communication) . Such large structures represent a feature unique to AHSV among the orbiviruses investigated. In this context it is noteworthy that the rotavirus nucleocapsid protein, VP6, which forms hexameric ring-like units on the surface of the inner capsid, can be purified from single-shelled rotavirus particles and assembles in vitro into hexamers, hexagonal lattices, and tubular and spherical particles depending on the pH (Ready & Sabara, 1987) . Similarly, small hexagonal lattices of BTV VP7 can be observed in preparations of partially disrupted BTV core particles or core-like particles synthesized by co-expression of BTV VP3 and VP7 using a dual recombinant baculovirus (French & Roy, 1990; unpublished data) . Further experiments on AHSV VP7 are required to elucidate the nature of the interactions controlling the mode of its polymerization and assembly into crystalline stuctures, as well as into single-shelled and double-shelled virus particles during AHSV morphogenesis. The ability of AHSV VP7 to form morphological structures was utilized to purify the protein by onestep sucrose gradient centrifugation; VP7 was present in one major fraction and essentially homogeneous. The availability of large amounts of homogeneous VP7 protein will facilitate crystallographic analyses.
